297 related articles for article (PubMed ID: 9678718)
1. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARalpha-mediated signals in myeloid leukemic cells.
Ueno H; Kizaki M; Matsushita H; Muto A; Yamato K; Nishihara T; Hida T; Yoshimura H; Koeffler HP; Ikeda Y
Leuk Res; 1998 Jun; 22(6):517-25. PubMed ID: 9678718
[TBL] [Abstract][Full Text] [Related]
2. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
3. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
5. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.
Mehta K; McQueen T; Neamati N; Collins S; Andreeff M
Cell Growth Differ; 1996 Feb; 7(2):179-86. PubMed ID: 8822201
[TBL] [Abstract][Full Text] [Related]
6. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
Brooks SC; Kazmer S; Levin AA; Yen A
Blood; 1996 Jan; 87(1):227-37. PubMed ID: 8547646
[TBL] [Abstract][Full Text] [Related]
7. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60.
Grillier I; Umiel T; Elstner E; Collins SJ; Koeffler HP
Leukemia; 1997 Mar; 11(3):393-400. PubMed ID: 9067579
[TBL] [Abstract][Full Text] [Related]
8. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.
Mehta K; McQueen T; Manshouri T; Andreeff M; Collins S; Albitar M
Blood; 1997 May; 89(10):3607-14. PubMed ID: 9160665
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
10. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells.
Kizaki M; Ikeda Y; Tanosaki R; Nakajima H; Morikawa M; Sakashita A; Koeffler HP
Blood; 1993 Dec; 82(12):3592-9. PubMed ID: 8260698
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR.
Monczak Y; Trudel M; Lamph WW; Miller WH
Blood; 1997 Nov; 90(9):3345-55. PubMed ID: 9345016
[TBL] [Abstract][Full Text] [Related]
12. Existence of retinoic acid-receptor-independent retinoid X-receptor-dependent pathway in myeloid cell function.
Hida T; Tai K; Tokuhara N; Ishibashi A; Kikuchi K; Hibi S; Yoshimura H; Nagai M; Yamauchi T; Kobayashi S
Jpn J Pharmacol; 2001 Jan; 85(1):60-9. PubMed ID: 11243576
[TBL] [Abstract][Full Text] [Related]
13. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
14. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
15. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
16. Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells.
Nagy L; Thomázy VA; Chandraratna RA; Heyman RA; Davies PJ
Leuk Res; 1996 Jun; 20(6):499-505. PubMed ID: 8709622
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Karászi E; Fésüs L
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells.
Agarwal N; Mehta K
Biochem Biophys Res Commun; 1997 Jan; 230(2):251-3. PubMed ID: 9016759
[TBL] [Abstract][Full Text] [Related]
19. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.
Hsu CA; Rishi AK; Su-Li X; Gerald TM; Dawson MI; Schiffer C; Reichert U; Shroot B; Poirier GG; Fontana JA
Blood; 1997 Jun; 89(12):4470-9. PubMed ID: 9192771
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells.
Ikezoe T; Tanosaki S; Krug U; Liu B; Cohen P; Taguchi H; Koeffler HP
Blood; 2004 Jul; 104(1):237-42. PubMed ID: 15026318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
